Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1990 Dec 15;143(12):1323–1326.

Plasma therapy for severe hemolytic-uremic syndrome in children in Atlantic Canada.

M R Ogborn 1, J F Crocker 1, D R Barnard 1
PMCID: PMC1452947  PMID: 2253139

Abstract

Clinical reports have suggested that therapy with fresh frozen plasma is a useful adjunct in the management of the hemolytic-uremic syndrome (HUS). We reviewed the charts of 36 children with severe HUS who were treated at the Izaac Walton Killam Hospital for Children, Halifax, over 10 years to assess the effectiveness of plasma therapy. All children who required specific supportive therapy for renal dysfunction, hemolysis or serious extrarenal complications were included. We compared the outcome of 18 children who received plasma therapy from 1982 to 1987 with that of 18 children who did not. The two groups were similar with regard to the severity of HUS, the length of hospital stay, the duration of renal dysfunction and the incidence of disease-related complications, such as seizures, enterocolitis and cardiomyopathy. At discharge the prevalence of hypertension was higher in the plasma therapy group than in the control group. Plasma therapy did not demonstrate any benefit that would outweigh the risk of fluid overload, hyperproteinemia and transmission of viral infection.

Full text

PDF
1323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom A., Hannaford P. A., Greaves M., Preston F. E., Brown C. B. Hemolytic-uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2. Clin Nephrol. 1985 Feb;23(2):85–88. [PubMed] [Google Scholar]
  2. Byrnes J. J., Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med. 1977 Dec 22;297(25):1386–1389. doi: 10.1056/NEJM197712222972507. [DOI] [PubMed] [Google Scholar]
  3. Chen Y. C., McLeod B., Hall E. R., Wu K. K. Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura. Lancet. 1981 Aug 8;2(8241):267–269. doi: 10.1016/s0140-6736(81)90522-5. [DOI] [PubMed] [Google Scholar]
  4. Eddy A. A., Geary D. F., Balfe J. W., Clark W. F., Baumal R. Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy. Pediatr Nephrol. 1989 Oct;3(4):420–423. doi: 10.1007/BF00850219. [DOI] [PubMed] [Google Scholar]
  5. Loirat C., Sonsino E., Hinglais N., Jais J. P., Landais P., Fermanian J. Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol. 1988 Jul;2(3):279–285. doi: 10.1007/BF00858677. [DOI] [PubMed] [Google Scholar]
  6. Powell H. R., Groves V., McCredie D. A., Yong A., Pitt J. Low red cell arachidonic acid in hemolytic uremic syndrome. Clin Nephrol. 1987 Jan;27(1):8–10. [PubMed] [Google Scholar]
  7. Remuzzi G., Misiani R., Marchesi D., Livio M., Mecca G., de Gaetano G., Donati M. B. Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet. 1978 Oct 21;2(8095):871–872. doi: 10.1016/s0140-6736(78)91573-8. [DOI] [PubMed] [Google Scholar]
  8. Rizzoni G., Claris-Appiani A., Edefonti A., Facchin P., Franchini F., Gusmano R., Imbasciati E., Pavanello L., Perfumo F., Remuzzi G. Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr. 1988 Feb;112(2):284–290. doi: 10.1016/s0022-3476(88)80071-4. [DOI] [PubMed] [Google Scholar]
  9. Schlegel N., Maclouf J., Loirat C., Drouet L., Marotte R., Scarabin P. Y., Mathieu H. Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome. J Pediatr. 1987 Jul;111(1):71–77. doi: 10.1016/s0022-3476(87)80344-x. [DOI] [PubMed] [Google Scholar]
  10. Spencer C. D., Crane F. M., Kumar J. R., Alving B. M. Treatment of postpartum hemolytic uremic syndrome with plasma exchange. JAMA. 1982 May 28;247(20):2808–2809. [PubMed] [Google Scholar]
  11. Stuart M. J., Spitzer R. E., Walenga R. W., Boone S. Prostanoids in hemolytic uremic syndrome. J Pediatr. 1985 Jun;106(6):936–939. doi: 10.1016/s0022-3476(85)80243-2. [DOI] [PubMed] [Google Scholar]
  12. Trompeter R. S., Schwartz R., Chantler C., Dillon M. J., Haycock G. B., Kay R., Barratt T. M. Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch Dis Child. 1983 Feb;58(2):101–105. doi: 10.1136/adc.58.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES